Cash & equivalents decreased 23.4%
Cash & equivalents changed -23.4% from the comparable as-filed period.
$151.0M→$115.7M2 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -23.4% from the comparable as-filed period.
SBC / revenue changed -28 basis points from the comparable as-filed period.
Selling, general & administrative changed -8.5% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.